Ligand Pharmaceuticals
LGND
116 hedge funds and large institutions have $640M invested in Ligand Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
83.68% more ownership
Funds ownership: 0% → 83.68% (+84%)
3% less call options, than puts
Call options by funds: $4.19M | Put options by funds: $4.33M
Top Buyers
Top Sellers
LGND Hedge Fund Activity: Q2 2013 in Review
116 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Ligand Pharmaceuticals (LGND) for Q2 2013, worth a combined $640M.
Buyers outnumbered sellers: 116 funds opened new LGND positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.
- 116 institutional investors held Ligand Pharmaceuticals (LGND) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $640M of Ligand Pharmaceuticals stock for Q2 2013.
- 116 funds opened new Ligand Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +116 holders.
Based on aggregated 13F filings for Q2 2013.